Genetics of Fatty Liver Disease in Children

Conditions

Non Alcoholic Fatty Liver Disease

What is the purpose of this trial?

This is a study to investigate genetic predisposition to hepatic steatosis and the expression of gluconeogenic and lipogenic genes in livers of obese children and adolescents.

Hypothesis 1: Common variants recently associated with variation in plasma TG levels identified in Genome Wide Association Studies (GWAS) (such as GCKR, PNPLA3) can affect accumulation of fat and subsequent development of Non Alcoholic Fatty Liver Disease (NAFLD). Gene variants act in additive or synergistic manner with progressive liver fat accumulation per additional risk allele.

Hypothesis 2: With increase in hepatic fat content NASH and fibrosis will increase. Furthermore, expression of lipogenic markers (SREBP1c) will increase.


Participation Guidelines

Age:
7 Years - 18 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
National Institute of Child Health and Human Development
Dates:
07/28/2011
Last Updated:
Study HIC#:
1104008388